Clinical Trial Update: Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase [NA]

View source ↗

Summary

A clinical trial evaluating embolectomy for acute Sylvian thrombosis in patients refractory or ineligible to alteplase has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Stroke, Acute | NA | Status: TERMINATED